![Cynthia Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Anderson
Inga fler pågående positioner
Profil
Cynthia L.
Anderson formerly worked at Alnylam Pharmaceuticals, Inc., as Chief Accounting Officer from 2019 to 2023 and Vistagen Therapeutics, Inc., as Chief Financial Officer from 2023 to 2025.
Ms. Anderson received her undergraduate degree from the University of Connecticut and graduate degree from The University of Texas at Dallas.
Tidigare kända positioner av Cynthia Anderson
| Företag | Position | Slut |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Finansdirektör/CFO | 2025-09-15 |
| ALNYLAM PHARMACEUTICALS, INC. | Comptroller/Controller/Revisor | 2023-01-01 |
Cynthia Andersons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
41
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Dallas
 The University of Texas at Dallas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
